Feedback / Questions
IOS-1002 - ImmunOs Therap
Keytruda (pembrolizumab) - Merck (MSD)
http://clinicaltrials.gov/ct2/show/NCT05763004
Jan 26, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next